Crosstalk between mitochondrial permeability transition and ETC supercomplexes in myocardial infarction
心肌梗死中线粒体通透性转变与 ETC 超复合物之间的串扰
基本信息
- 批准号:9769807
- 负责人:
- 金额:$ 37.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-22 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:ATP Synthesis PathwayAccountingAcute myocardial infarctionAnimal ModelCalciumCardiacCardiac MyocytesCardiolipinsCell DeathCell SurvivalCessation of lifeClinicalComplexCoronary arteryCoronary heart diseaseDevelopmentDiffusionDissociationElectron TransportElectronsEnergy MetabolismExtravasationHeartIn VitroIndividualInjuryInner mitochondrial membraneIschemiaKnowledgeLigationMediatingMitochondriaMitochondrial SwellingModelingMolecularMorbidity - disease rateMusMyocardial InfarctionMyocardial IschemiaMyocardial dysfunctionOrganellesOutcomeOxidative PhosphorylationOxidative StressOxidesPathogenesisPathologicPatientsPermeabilityPhospholipidsPlayProductionRattusReactive Oxygen SpeciesReperfusion InjuryReperfusion TherapyRoleTherapeutic InterventionTimeTreatment EfficacyUnited Statescardioprotectioncoronary perfusioneffective therapyimprovedin vivoin vivo Modelinhibitor/antagonistinorganic phosphateinsightknock-downmitochondrial permeability transition poremortalitynovel therapeutic interventionoxidationpreventresponserestorationsanglifehrin Asolid statetargeted treatmenttert-Butylhydroperoxide
项目摘要
ABSRACT
Coronary heart disease is the leading cause of morbidity and mortality worldwide. Timely restoration of coronary
perfusion known as reperfusion is the only effective therapeutic intervention for protecting the heart from
myocardial infarction (MI). Currently, there is no effective therapy for preventing cardiac ischemia-reperfusion
(IR) injury. The loss of mitochondrial function plays a crucial role in IR-induced cell death suggesting that
protection and restoration of mitochondrial function is pivotal to cell survival in the heart. However, limited
knowledge of the mechanisms underlying mitochondria-mediated cell death obscures the development of new
mitochondria-targeted cardioprotective compounds. Cardiac IR increases calcium, reactive oxygen species
(ROS), and inorganic phosphate levels in mitochondria that induce mitochondrial permeability transition (MPT)
concurrently with opening of the non-specific pathological MPT pores in the inner mitochondrial membrane. High
mitochondrial ROS (mtROS) also may disintegrate mitochondrial supercomplexes (SCs), predominantly due to
oxidation of cardiolipin (CL), a unique mitochondrial phospholipid. SCs are large supramolecular complexes
containing individual electron transport chain (ETC) complexes. According to the solid-state model, the assembly
of SCs provides high-efficiency electron flux throughout the ETC; it increases ATP synthesis and significantly
reduces electron leakage and mtROS production due to short diffusion distances between ETC complexes. The
cause-and-effect relationship between MPT induction and SC degradation has not yet been established. We
hypothesize that the MPT plays a causal role in the disintegration of mitochondrial SCs, leading to diminished
energy metabolism and cell death in cardiac IR. We propose that MPT-induced mitochondrial swelling sensitizes
CL to the ROS attack leading to degradation of SCs. The Specific Aims are as follows: (1) Determine the
timing of MPT, disintegration of SCs and progression of post-MI injury. We will investigate the association
between MPT pore opening and SC degradation, with progression of IR injury, using the animal model of in vivo
MI induced by coronary artery ligation with/without subsequent reperfusion. We will also subject WT and tafazzin
knockdown (TazKD) mice to cardiac IR to distinguish changes in SC assembling induced by CL oxidation versus
CL deficiency. (2) Examine the cause-and-effect relationship between the MPT induction and SC disintegration
in response to oxidative stress. We will subject cardiomyocytes/mitochondria with CyP-D (Ppif) and/or tafazzin
deficiency to oxidative stress to clarify a cause-and-effect relationship between MPT and SC disintegration. In
addition, cardiac mitochondria will be treated with oxidized CL in the presence of MPT inducers/blockers to reveal
a causal role of MPT versus CL oxidation in SC degradation. (3) Define if inhibition of MPT, and mtROS
scavenging protect synergistically against post-MI injury. These studies will establish whether combined therapy
simultaneously targeting mtROS and MPT exerts synergistic cardioprotective effects on cardiac IR. The MPT
inhibitor will be administered alone or in combination with mtROS scavengers during in vivo cardiac IR. In
addition, WT and TazKD hearts will be subjected to ex vivo IR in the presence of the MPT inhibitor and/or mtROS
scavengers. Overall, elucidating the crosstalk mechanisms between MPT and SC degradation will provide new
insights into the molecular basis of mitochondria-mediated cell death during cardiac IR. The outcome of this
project will allow development of new therapeutic strategies to prevent myocardial IR injury, and improve clinical
consequences in patients with acute myocardial infarction through targeting mitochondria.
摘要
冠心病是世界范围内发病率和死亡率的主要原因。及时恢复冠脉
被称为再灌注的灌注是保护心脏免于再灌注的唯一有效的治疗干预。
心肌梗死(MI)。目前,尚无有效的治疗方法来预防心脏缺血-再灌注
(IR)损伤线粒体功能的丧失在IR诱导的细胞死亡中起着至关重要的作用,这表明
线粒体功能的保护和恢复对于心脏中的细胞存活至关重要。但受限
对大肠杆菌介导的细胞死亡机制的了解掩盖了新的
靶向心脏保护化合物。心脏IR增加钙,活性氧
(ROS)和诱导线粒体通透性转换(MPT)的线粒体中的无机磷酸盐水平
同时开放线粒体内膜中的非特异性病理性MPT孔。高
线粒体ROS(mtROS)也可以分解线粒体超复合物(SC),主要是由于
心磷脂(CL),一种独特的线粒体磷脂的氧化。SC是一种大的超分子复合物
含有单独的电子传递链(ETC)复合物。根据固态模型,
的SC在整个ETC中提供了高效的电子通量;它增加了ATP的合成,
由于ETC复合物之间的短扩散距离,减少了电子泄漏和mtROS的产生。的
MPT诱导和SC降解之间的因果关系尚未确定。我们
假设MPT在线粒体SC的解体中起着因果作用,导致减少
能量代谢和细胞死亡的心脏IR。我们提出,MPT诱导的线粒体肿胀敏化
CL对ROS的攻击导致SC的降解。具体目标如下:(1)确定
MPT的时间、SC的崩解和MI后损伤的进展。我们会调查
使用体内的动物模型,
冠状动脉结扎伴/不伴后续再灌注诱导MI。我们也会让WT和tafazzin
敲低(TazKD)小鼠心脏IR,以区分CL氧化诱导的SC组装变化与
CL缺乏症。(2)检查MPT诱导和SC崩解之间的因果关系
对氧化应激的反应。我们将心肌细胞/线粒体与CyP-D(Ppif)和/或tafazzin
缺乏氧化应激,以澄清MPT和SC崩解之间的因果关系。在
此外,将在MPT诱导剂/阻断剂存在下用氧化CL处理心脏线粒体,以揭示
MPT与CL氧化在SC降解中的因果作用。(3)定义是否抑制MPT和mtROS
清除协同保护心肌梗死后损伤。这些研究将确定联合治疗是否
同时靶向mtROS和MPT对心脏IR发挥协同的心脏保护作用。
在体内心脏IR期间,将单独或与mtROS清除剂组合施用抑制剂。
此外,WT和TazKD心脏将在MPT抑制剂和/或mtROS存在下进行离体IR
食腐动物总的来说,阐明MPT和SC退化之间的串扰机制将提供新的
深入了解心脏IR期间细胞死亡的分子基础。
该项目将允许开发新的治疗策略,以防止心肌IR损伤,并改善临床
通过靶向线粒体治疗急性心肌梗死患者。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Current Challenges in Elucidating Respiratory Supercomplexes in Mitochondria: Methodological Obstacles.
- DOI:10.3389/fphys.2018.00238
- 发表时间:2018
- 期刊:
- 影响因子:4
- 作者:Jang S;Javadov S
- 通讯作者:Javadov S
Structural and functional remodeling of mitochondria as an adaptive response to energy deprivation.
- DOI:10.1016/j.bbabio.2021.148393
- 发表时间:2021-06-01
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mitochondria and ferroptosis
- DOI:10.1016/j.cophys.2022.100483
- 发表时间:2022-02-02
- 期刊:
- 影响因子:2.5
- 作者:Javadov, Sabzali
- 通讯作者:Javadov, Sabzali
Computational Modeling of In Vitro Swelling of Mitochondria: A Biophysical Approach.
- DOI:10.3390/molecules23040783
- 发表时间:2018-03-28
- 期刊:
- 影响因子:0
- 作者:Makarov VI;Khmelinskii I;Javadov S
- 通讯作者:Javadov S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sabzali Javadov其他文献
Sabzali Javadov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sabzali Javadov', 18)}}的其他基金
Mitochondria-mediated mechanisms of ferroptosis in response to cardiac ischemia-reperfusion injury
线粒体介导的铁死亡响应心脏缺血再灌注损伤的机制
- 批准号:
10681495 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
Mitochondria-mediated mechanisms of ferroptosis in response to cardiac ischemia-reperfusion injury
线粒体介导的铁死亡响应心脏缺血再灌注损伤的机制
- 批准号:
10409003 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
Crosstalk between mitochondrial permeability transition and ETC supercomplexes in myocardial infarction
心肌梗死中线粒体通透性转变与 ETC 超复合物之间的串扰
- 批准号:
9207161 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart F
线粒体通透性转变作为心脏 F 心脏保护的目标
- 批准号:
8535195 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Crosstalk between mitochondrial permeability transition and ETC supercomplexes in myocardial infarction
心肌梗死中线粒体通透性转变与 ETC 超复合物之间的串扰
- 批准号:
9551649 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart F
线粒体通透性转变作为心脏 F 心脏保护的目标
- 批准号:
8676936 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart F
线粒体通透性转变作为心脏 F 心脏保护的目标
- 批准号:
9053516 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart F
线粒体通透性转变作为心脏 F 心脏保护的目标
- 批准号:
8337107 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Mitochondrial Permeability Transition as a Target for Cardioprotection in Heart F
线粒体通透性转变作为心脏 F 心脏保护的目标
- 批准号:
8852176 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 37.5万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别: